Study S000100

Effect of Liraglutide on Macrophage Polarization in Human Adipose Tissue and Peripheral Blood

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02650206
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: TRIPLE
Status: COMPLETED
Enrollment: 56
Start: 2015-01
Primary completion: 2019-09-27
Lead sponsor: Stanford University
Conditions: Diabetes Mellitus, Type 2; Diabetes Mellitus, Type II; Diabetes Mellitus, Adult-Onset; Inflammation
Interventions: DRUG:Victoza (liraglutide) with dietician monitoring; OTHER:Placebo with dietician monitoring
Results posted: FALSE

Registered primary outcomes

Macrophage polarization: % M2 macrophages in adipose tissue and peripheral blood according to positivity for cell surface markers (measured by flow cytometry). [30 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.